Fulcrum Therapeutics, Inc. Common Stock (FULC) is a publicly traded Healthcare sector company. As of July 16, 2026, FULC trades at $3.74 with a market cap of $239.21M and a P/E ratio of -22.09. FULC moved -0.56% today. Year to date, FULC is -68.52%; over the trailing twelve months it is -54.59%. Its 52-week range spans $2.32 to $15.74. Analyst consensus is sell with an average price target of $3.43. Rallies surfaces FULC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest FULC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $3.74 |
| Market Cap | $239.21M |
| P/E Ratio | -22.09 |
| EPS | $-0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.74 |
| 52-Week Low | $2.32 |
| Volume | 809.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $80.00M |
| Net Income | $-9.72M |
| Gross Margin | 0.00% |
8 analysts cover FULC: 0 strong buy, 0 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is sell. Average price target: $3.43.